Malaysia and Thailand Test a Faster Path for Medical Device Oversight

Malaysia and Thailand’s decision to implement a medical device reliance programme is a meaningful development for regional regulation. In practice, reliance models allow regulators to leverage the work of trusted counterparts, reducing duplication and potentially speeding access to approved technologies.

That may sound procedural, but it has real commercial and clinical implications. Faster reviews can improve time-to-market for manufacturers and accelerate patient access to devices that have already been vetted elsewhere. In markets where regulatory backlog can delay innovation, this is one of the clearest ways to improve system efficiency without lowering standards.

The broader trend is toward regulatory pragmatism. Health systems increasingly recognize that not every country needs to recreate the full evaluation process from scratch, especially for products already cleared by mature agencies. The challenge is ensuring that reliance does not become blind dependence; local context, intended use, and post-market monitoring still matter.

If the pilot’s success holds up, this could become a model for other middle-income regulators. It also signals to device companies that regulatory strategy in Asia is becoming more networked, and that building strong international evidence packages may yield faster regional expansion.